Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
B
Biogend Therapeutics Co Ltd
TPEX:6733
Biogend Therapeutics Co Ltd
TPEX:6733
Price:
24.55
TWD
-0.2%
Market Closed
Market Cap:
NT$3.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Biogend Therapeutics Co Ltd
TPEX:6733
|
TW |
|
I
|
Igiant Optics Co Ltd
TPEX:6915
|
TW |
|
Endurance Motive SA
F:7VB
|
ES |
|
R
|
Regenxbio Inc
F:RB0
|
US |
|
V
|
Viking Holdings Ltd(Pembroke)
NYSE:VIK
|
BM |
|
R
|
Rosbank PAO
MOEX:ROSB
|
RU |
|
S
|
Sierra Madre Gold and Silver Ltd
F:409
|
CA |
|
Solidion Technology Inc
NASDAQ:STI
|
US |
|
D
|
DCC PLC
OTC:DCCPY
|
IE |
|
W
|
Wereldhave NV
F:WER
|
NL |
|
L
|
Leather Up Ltd
KAR:LEUL
|
PK |
|
T
|
Topco Technologies Corp
TPEX:3388
|
TW |
|
d'Amico International Shipping SA
MIL:DIS
|
LU |
|
I
|
ICU Medical Inc
F:IC7
|
US |
|
A
|
Ayala Corp
OTC:AYALY
|
PH |
|
Arctic Fish Holding AS
F:6TW
|
NO |
|
K
|
Kalbe Farma Tbk PT
F:LCLA
|
ID |
|
M
|
Multipolar Tbk PT
XMUN:MLQ2
|
ID |
|
C
|
Central Azucarera de Tarlac Inc
XPHS:CAT
|
PH |
|
P
|
Prim SA
SWB:5P1
|
ES |
|
E
|
Euwax AG
F:EUX
|
DE |
|
I
|
IOVTEC Co Ltd
TPEX:7583
|
TW |
|
E
|
Exagen Inc
F:E08A
|
US |
|
A
|
Ahmedabad Steel Craft Ltd
BSE:522273
|
IN |
Wall St Price Targets
Price Forecast
Based on 3 analysts
Based on 3 analysts
+66% Upside
from
NT$24.55
today
Biogend Therapeutics Co Ltd (6733)’s 12-month stock price forecast through October 2027 has a consensus target of NT$40.8, implying 66% upside. The forecast is based on price targets from 3 Wall Street analysts.
Biogend Therapeutics Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Biogend Therapeutics Co Ltd's stock price target?
Price Target
40.8
TWD
40.8
TWD
According to Wall Street analysts, the average 1-year price target for Biogend Therapeutics Co Ltd is 40.8 TWD with a low forecast of 40.4 TWD and a high forecast of 42 TWD.
What is the Revenue forecast for Biogend Therapeutics Co Ltd?
Projected CAGR
30%
30%
The compound annual growth rate for Revenue over the next 1 year is 30%.
What is the Gross Profit forecast for Biogend Therapeutics Co Ltd?
Projected CAGR
31%
31%
The compound annual growth rate for Gross Profit over the next 1 year is 31%.